Dissection of systems, cell populations and molecules

Scandinavian Journal of Immunology, Supplement

Volumn 62, Issue 1, 2005, Pages 62-66

  Benner, R ^a   Khan, N A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; CONCANAVALIN A; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; PROTEIN SUBUNIT;

ALLOGRAFT; ALLOIMMUNIZATION; AMINO ACID SEQUENCE; ANGIOGENESIS; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE MARROW; CELL POPULATION; DIABETES MELLITUS; DILUTION; DISSECTION; GENE EXPRESSION; GRAFT REJECTION; HUMAN; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION; LYMPH NODE; MEMORY CELL; MULTIPLE SCLEROSIS; NONHUMAN; PEPTIDE SYNTHESIS; PLASMA CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; T LYMPHOCYTE;

EID: 23744459488     PISSN: 03016323     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01611.x     Document Type: Review

References (47)

1. Oden ThC, ed. Parables of Kierkegaard. Princeton, New Jersey: Princeton University Press, 1978.
2. Lefkovits I, ed. A Portrait of the Immune System. Scientific Publications of N.K. Jerne. Singapore: World Scientific Publishing Co, Pte. Ltd., 1996.
3. van der Blom N. Rotterdam and Erasmus. In: Sperna Weiland J, Frijhoff WThM, eds. Erasmus of Rotterdam. The man and the scholar. Proceedings of the Symposium Held at the Erasmus University, Rotterdam. Leiden: Brill Academic Publications, 1988:240-52.
4. Pfeiffer R, Marx. Die Bildungsstätte der Choleraschutzstoffe. Z Hyg U Infektionskrankh 1898;27:272-97.
5. Deutsch L. Contribution à l'étude de l'origine des anticorps typhiques. Ann Inst Past 1899;9:689-727.
6. Benner R, Meima F, van der Meulen GM, van Ewijk W. Antibody formation in bone marrow. III. Effects of route of priming and antigen dose. Immunology 1974;27:747-60.
7. Benner R, Meima F, van der Meulen GM. Antibody formation in bone marrow. II. Evidence for a memory-dependent phenomenon. Cell Immunol 1974;13:95-106.
8. Benner R, van Oudenaren A, de Ruiter H. Antibody formation in bone marrow. IX. Peripheral lymphoid organs are involved in the initiation of bone marrow antibody formation. Cell Immunol 1977;34:125-37.
9. Benner R. The bone marrow: a major site of antibody production. In: Steinberg CM, Lefkovits I, eds. Festschrift in Honor of Niels Kaj Jerne on the Occasion of His 70th Birthday. Basel: S Karger, 1981:362-71.
10. Benner R, van Oudenaren A, Koch G. Induction of antibody formation in mouse bone marrow. In: Lefkovits I, Pernis B, eds. Immunological Methods II. New York: Academic Press, 1981:247-61.
11. Koch G, Osmond DG, Julius MH, Benner R. The mechanism of thymus-dependent antibody formation in bone marrow. J Immunol 1981;126:887-90.
12. Slifka MK, Matloubian M, Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 1995;69:1895-902.
13. Hargreaves DC, Hyman PL, Lu TT et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001;194:45-56.
14. Han S, Yang K, Ozen Z et al. Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice. J Immunol 2003;170:1267-73.
15. Cassese G, Arce S, Hauser AE et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 2003;171:1684-90.
16. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol 2003;3:822-9.
17. O'Connor BP, Raman VS, Erickson LD et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004;199:91-7.
18. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 2003;170:1136-40.
19. Lefkovits I, Waldmann H. Limiting Dilution Analysis of Cells in the Immune System. Oxford: University Press, 1999.
20. Benner R, Rijnbeek A-M, Schreier MH, Coutinho A. Frequency analysis of immunoglobulin v-gene expression and functional reactivities in bone marrow B cells. J Immunol 1981;126:887-90.
21. Benner R, Coutinho A, Rijnbeek A-M, van Oudenaren A, Hooijkaas H. Immunoglobulin isotype expression. II. Freqency analysis in mitogen-reactive B cells. Eur J Immunol 1981;11:799-804.
22. Hooijkaas H, van der Linde-Preesman AA, Bitter WM, Benner R, Pleasants JR, Wostmann BS. Frequency analysis of functional immunoglobulin c- and v-gene expression by mitogen-reactive B cells in germfree mice fed chemically defined ultra-filtered 'antigen-free' diet. J Immunol 1985;134:2223-7.
23. Hooijkaas H, Preesman AA, van Oudenaren A, Benner R, Haaijman JJ. Frequency analysis of functional immunoglobulin c and v gene expression in murine B cells at various ages. J Immunol 1983;131:1629-34.
24. Benner R, Wolters EAJ, Bril H, Molendijk A, van Oudenaren A. Regulation of delayed type hypersensitivity to host histocompatibility antigens during graft-versus-host reactions. Immunol Rev 1985;88:25-57.
25. Aarden L, Corley RB, Soederberg A, Lefkovits I. Limiting dilution analysis of the suppressive effect mediated by alloantigen-primed cells. Immunology 1980;41:399-406.
26. Bianchi ATJ, Schilham MW, Benner R, Young P, Lefkovits I. In vivo priming of helper and suppressor T cells by alloantigens. Frequency analysis with the use of an in vitro limiting dilution assay. J Immunol 1987;139:2524-9.
27. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999;20:114-8.
28. McCracken SA, Gallery E, Morris JM. Pregnancy-specific downregulation of NF-kappa B expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success. J Immunol 2004;172:4583-91.
29. Goretzlehner G, Rudolf K. 50 years ago - 1927 - the 1st demonstration of chorionic gonadotropin in the urine of pregnant women by Aschheim and Zondek. Zentralbl Gynakol 1978;100:638-41.
30. Yoshimoto Y, Wolfsen AR, Hirose F, Odell WD. Human chorionic gonadotropin-like material: presence in normal human tissues. Am J Obstet Gynecol 1979;134:729-33.
31. Birken S, Maydelman Y, Gawinowicz MA, Pound A, Liu Y, Hartree AS. Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology 1996;137:1402-11.
32. Amoroso EC, Perry JS. The existence during gestation of an immunological buffer zone at the interface between maternal and foetal tissues. Philos Trans R Soc Lond B Biol Sci 1975;271:343-61.
33. Cole LA, Kardana A, Park S-Y, Braunstein GD. The deactivation of hCG by nicking and dissociation. J Clin Endocr Metab 1993;76:704-10.
34. Alfthan H, Stenman UH. Pathophysiological importance of various molecular forms of human choriogonadotropin. Mol Cell Endocrinol 1996;125:107-20.
35. Kardana A, Elliott MM, Gawinowicz MA, Birken S, Cole LA. The heterogeneity of human chorionic gonadotropin (hCG). I. Characterization of peptide heterogeneity in 13 individual preparations of hCG. Endocrinology 1991;129:1541-50.
36. Cole LA, Kardana A, Andrade-Gordon P et al. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Endocrinology 1991;129:1559-67.
37. Birken S, Maydelman Y, Gawinowicz MA. Preparation and analysis of the common urinary forms of human chorionic gonadotropin. Methods 2000;21:3-14.
38. Khan NA, Benner R. Immunoregulator. European Patent Application EP00.201.139.3 (29 March 2000). International Patent Application PCT/NL01/00259 (29 March 2001, granted).
39. Khan NA, Benner R. Gene regulation by peptides. European Patent Application EP01.203.748.7 (4 October 2001). International Patent Application PCT/NL02/00639 (4 October 2002, granted).
40. Khan NA, Khan A, Savelkoul HFJ, Benner R. Inhibition of septic shock in mice by an oligopeptide from the β-chain of human chorionic gonadotrophin hormone. Hum Immunol 2002;63:1-7.
41. Lefkovits I, Kettman JR, Coleclough C. A strategy for founding a global lymphocyte proteinpaedia and gene catalogue. Immunol Today 1990;11:157-62.
42. Frey JR, Kuhn L, Kettman JR, Lefkovits I. The amino acid composition of 350 lymphocyte proteins. Mol Immunol 1994;31:1219-31.
43. Futaki S, Goto S, Suzuki T, Nakase I, Sugiura Y. Structural variety of membrane permeable peptides. Curr Protein Pept Sci 2003;4:87-96.
44. Nathan C. Points of control in Inflammation. Nature 2002;420:846-91.
45. Oyama J, Biais C, Liu X et al. Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice. Circulation 2004;109:784-9.
46. 2-terminal kinase activity improves ischemia/reperfusion injury in rat lungs. J Immunol 2004;172:2569-77.
47. Lopez-Otin C, Overall CM. Protease degradomics: a new challenge for proteomics. Nature Rev Mol Cell Biol 2002;3:509-19.